Jesus Castro Marrero Jesús Castro is currently a Senior Postdoctoral Researcher linked to the Vall d'Hebron University Hospital Research Institute (VHIR) since 2000. In the last 20 years, Dr. Castro has dedicated themselves to basic research in autoimmune and rheumatic diseases with more than 50 publications and book chapters high impact He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain. Institutions of which they are part Postdoctoral researcher Rheumatology Vall Hebron Institut de Recerca Jesus Castro Marrero Institutions of which they are part Postdoctoral researcher Rheumatology Vall Hebron Institut de Recerca Jesús Castro is currently a Senior Postdoctoral Researcher linked to the Vall d'Hebron University Hospital Research Institute (VHIR) since 2000. In the last 20 years, Dr. Castro has dedicated themselves to basic research in autoimmune and rheumatic diseases with more than 50 publications and book chapters high impact He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain.
Jesus Castro earned his Postdoctoral Researcher Fellowship degree in Biochemistry and Molecular Biology program at the Valladolid University School of Medicine, Spain in 1999. Dr. Castro is currently a Senior Postdoctoral Research at the Vall d’Hebron Hospital Research Institute, University of Barcelona School of Medicine, Barcelona, Spain since 2002. In the past 20 years have been devoted to basic research of respiratory medicine, autoimmune and rheumatic conditions with over 50 high-impact factor publications and book chapters. He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain. Dr. Castro is a member of the E.U. CFS/ME Research Collaborative Consortium Initiative (European Myalgic Encephalomyelitis NEtwork-EUROMENE). His current research is focused on the bioenergetic metabolism, mitochondrial dysfunction, and neuroimmune pathways linked to the immune response in CFS/ME, as well as finding useful biomarkers to aid in the diagnosis, treatment, and management of CFS/ME through clinical trials in order to improve prognosis and quality of life of CFS/ME patients.
Projects Ensayo clínico aleatorizado y controlado para evaluar la eficacia de la azatioprina vs. micofenolato sódico para el tratamiento de la fase de inducción y mantenimiento de la remisión de los brotes extra renales del lupus eritematoso sistémico (EUDRA 2008 IP: Josefina Cortes Hernandez Collaborators: José Ordi Ros, Miguel Vilardell Tarres, Jesus Castro Marrero, Pilar Suñe Martin Funding agency: Ministerio Sanidad Funding: 213508.13 Reference: TRA-188 Duration: 01/01/2010 - 31/12/2013 Estudio para evaluar la eficacia y seguridad de la lenalidomida en el tratamiento del lupus eritematoso cutáneo IP: José Ordi Ros Collaborators: J. Bruno Montoro Ronsano, Josefina Cortes Hernandez, Jesus Castro Marrero Funding agency: Ministerio Sanidad Funding: 204000 Reference: TRA-194 Duration: 01/01/2010 - 31/12/2010 Autoimmunitat i malaltia trombòtica IP: Miguel Vilardell Tarres Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, José Ángel Bosch Gil, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 49920 Reference: 2009 SGR 661 Duration: 01/01/2010 - 30/04/2014 Lupus y Apoptosis: Mecanismo de acción de la talidomida y sus análogos en el lupus cutáneo refractario. Implicaciones clínicas y terapéuticas IP: Miguel Vilardell Tarres Collaborators: Vicente García-Patos Briones, Jesus Castro Marrero, Patricia Bassas Freixas Funding agency: Instituto de Salud Carlos III Funding: 13189 Reference: PI080112 Duration: 01/01/2009 - 31/12/2011 Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Next page › Last page »
